Author

M. Akram

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

J. C. Schmidt· 1 shared K. A. Gallo· 1 shared R. R. Neubig· 1 shared S. E. Conrad· 1 shared S. Misek· 1 shared T. Dexheimer· 1 shared

Activity by Year

2021-2021 · peak 1/yr

Co-Author Collaboration Network

6 top collaborators · 15 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

J. C. Schmidt

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

BRAF inhibitor resistance confers increased sensitivity to mitotic inhibitors

S. Misek, T. Dexheimer, M. Akram, S. E. Conrad, J. C. Schmidt, R. R. Neubig, K. A. Gallo

This study identifies that BRAF inhibitor-resistant melanoma cells are more sensitive to mitotic inhibitors, revealing a potential therapeutic strategy for resistant tumors.

bioRxiv · Apr 15, 2021Cancer Biology